{"id":"https://openalex.org/W2056535857","doi":"https://doi.org/10.4161/cc.4.10.2105","title":"Biomarkers to Predict Response to Epidermal Growth Factor Receptor Inhibitors","display_name":"Biomarkers to Predict Response to Epidermal Growth Factor Receptor Inhibitors","publication_year":2005,"publication_date":"2005-09-23","ids":{"openalex":"https://openalex.org/W2056535857","doi":"https://doi.org/10.4161/cc.4.10.2105","mag":"2056535857","pmid":"https://pubmed.ncbi.nlm.nih.gov/16177570"},"language":"en","primary_location":{"id":"doi:10.4161/cc.4.10.2105","doi":"https://doi.org/10.4161/cc.4.10.2105","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cc.4.10.2105","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cc.4.10.2105?needAccess=true","source":{"id":"https://openalex.org/S86011449","display_name":"Cell Cycle","issn_l":"1538-4101","issn":["1538-4101","1551-4005"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Cycle","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.4161/cc.4.10.2105?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085032736","display_name":"Daphne Adele Haas-Kogan","orcid":"https://orcid.org/0000-0002-2378-4800","observed_orcids":["https://orcid.org/0000-0002-2378-4800"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daphne A. Haas-Kogan","raw_affiliation_strings":["Department of Radiation Oncology, University of California-San Francisco, USA. hkogan@radonc.17.ucsf.edu","Department of Radiation Oncology University of California San Francisco USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, University of California-San Francisco, USA. hkogan@radonc.17.ucsf.edu","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"Department of Radiation Oncology University of California San Francisco USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046264008","display_name":"Michael D. Prados","orcid":"https://orcid.org/0000-0002-9630-2075","observed_orcids":["https://orcid.org/0000-0002-9630-2075"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael D. Prados","raw_affiliation_strings":["Departments of Neurosurgery and Brain Tumor Research Center ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neurosurgery and Brain Tumor Research Center ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061018141","display_name":"Kathleen R. Lamborn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathleen R. Lamborn","raw_affiliation_strings":["Departments of Neurosurgery and Brain Tumor Research Center ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neurosurgery and Brain Tumor Research Center ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060842441","display_name":"Tar\u0131k Tihan","orcid":"https://orcid.org/0000-0003-4551-2555","observed_orcids":["https://orcid.org/0000-0003-4551-2555"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tarik Tihan","raw_affiliation_strings":["Department of Pathology ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006262715","display_name":"Mitchel Stuart Berger","orcid":"https://orcid.org/0000-0003-1983-4892","observed_orcids":["https://orcid.org/0000-0003-1983-4892"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitchel S. Berger","raw_affiliation_strings":["Departments of Neurosurgery and Brain Tumor Research Center ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Neurosurgery and Brain Tumor Research Center ;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082108617","display_name":"David Stokoe","orcid":"https://orcid.org/0000-0002-6333-5364","observed_orcids":["https://orcid.org/0000-0002-6333-5364"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Stokoe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.6712,"has_fulltext":true,"cited_by_count":70,"citation_normalized_percentile":{"value":0.93593711,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"4","issue":"10","first_page":"1369","last_page":"1372"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.6147000193595886,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.6147000193595886,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.22529999911785126,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.13660000264644623,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.9559999704360962},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.9789999723434448},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.8600000143051147},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9700000286102295},{"id":"https://openalex.org/keywords/response-prediction","display_name":"response prediction","score":0.4749999940395355},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.890999972820282},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8349999785423279},{"id":"https://openalex.org/keywords/egfr-amplification","display_name":"EGFR amplification","score":0.671999990940094},{"id":"https://openalex.org/keywords/egfr-overexpression","display_name":"EGFR overexpression","score":0.8149999976158142},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.5320000052452087}],"concepts":[{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.8907521963119507},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.8125176429748535},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7041956782341003},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.6352206468582153},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5717453360557556},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.532898485660553},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5279791951179504},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5109040141105652},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4826646149158478},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.43648597598075867},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4341890215873718},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4126027226448059},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2919902801513672},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.284451961517334},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4161/cc.4.10.2105","doi":"https://doi.org/10.4161/cc.4.10.2105","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cc.4.10.2105","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cc.4.10.2105?needAccess=true","source":{"id":"https://openalex.org/S86011449","display_name":"Cell Cycle","issn_l":"1538-4101","issn":["1538-4101","1551-4005"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Cycle","raw_type":"journal-article"},{"id":"pmid:16177570","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16177570","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell cycle (Georgetown, Tex.)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4161/cc.4.10.2105","doi":"https://doi.org/10.4161/cc.4.10.2105","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cc.4.10.2105","pdf_url":"https://www.tandfonline.com/doi/pdf/10.4161/cc.4.10.2105?needAccess=true","source":{"id":"https://openalex.org/S86011449","display_name":"Cell Cycle","issn_l":"1538-4101","issn":["1538-4101","1551-4005"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Cycle","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2056535857.pdf","grobid_xml":"https://content.openalex.org/works/W2056535857.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2104743043","https://openalex.org/W2055476710","https://openalex.org/W1980211974","https://openalex.org/W1979405808","https://openalex.org/W2086216067","https://openalex.org/W1983280054","https://openalex.org/W2039114751","https://openalex.org/W2151263077","https://openalex.org/W2977930699","https://openalex.org/W2074937243"],"abstract_inverted_index":{"Epidermal":[0],"growth":[1],"factor":[2],"receptors":[3],"(EGFRs)":[4],"are":[5,44,71],"amplified":[6],"and":[7,43,56,76,122,137,205],"overexpressed":[8],"in":[9,45,64,100,112,167],"many":[10],"different":[11],"human":[12],"cancers,":[13],"a":[14,94],"phenomenon":[15],"generally":[16,204],"associated":[17,27],"with":[18,28,102,154],"poor":[19],"prognosis.":[20],"Inhibitors":[21],"of":[22,37,90,98,124,134,146,170,174,184,192,200,208,215,222],"the":[23,35,106,143,168,175,190,213],"tyrosine":[24],"kinase":[25],"activity":[26],"this":[29,135],"receptor":[30],"have":[31],"been":[32],"approved":[33],"for":[34,48,152],"treatment":[36],"chemotherapy-refractory":[38],"nonsmall":[39],"cell":[40],"lung":[41],"cancer,":[42],"clinical":[46],"trials":[47,179,194],"additional":[49],"tumor":[50,77,111],"types.":[51],"While":[52],"these":[53,83,165,216],"inhibitors,":[54],"gefitinib":[55],"erlotinib,":[57],"display":[58],"limited":[59],"response":[60,160,209],"rates":[61],"when":[62],"assessed":[63],"cohorts":[65],"that":[66,79,116,142,180],"include":[67],"all":[68],"patients,":[69],"there":[70],"subgroups,":[72],"defined":[73],"by":[74],"patient":[75],"characteristics,":[78],"preferentially":[80,226],"respond":[81,227],"to":[82,161,182,195,210,219,228],"agents.":[84],"We":[85,114,139,163],"recently":[86],"performed":[87],"an":[88,149],"analysis":[89],"tumors":[91,119],"obtained":[92],"from":[93],"Phase":[95,177],"I":[96],"trial":[97],"erlotinib":[99],"patients":[101,117,129,223],"glioblastoma":[103],"multiforme":[104],"(GBM),":[105],"most":[107],"common":[108],"malignant":[109],"brain":[110],"adults.":[113],"showed":[115],"whose":[118],"exhibited":[120],"overexpression":[121],"amplification":[123],"EGFR":[125,185,229],"responded":[126],"better":[127],"than":[128],"who":[130,224],"had":[131],"normal":[132],"levels":[133,157],"gene":[136],"protein.":[138],"also":[140],"demonstrated":[141],"phosphorylation":[144],"state":[145],"PKB/Akt":[147],"was":[148],"important":[150],"determinant":[151],"response,":[153],"low":[155],"phospho-PKB/Akt":[156],"predicting":[158],"good":[159],"erlotinib.":[162],"discuss":[164],"findings":[166],"context":[169],"recent":[171],"molecular":[172],"analyses":[173],"placebo-controlled":[176,193],"III":[178],"led":[181],"approval":[183],"inhibitors.":[186,230],"These":[187],"data":[188],"underscore":[189],"importance":[191],"distinguish":[196],"between":[197],"prognostic":[198],"indicators":[199],"disease":[201],"progression":[202],"more":[203],"predictive":[206],"markers":[207],"therapy.":[211],"Ultimately":[212],"goal":[214],"studies":[217],"is":[218],"allow":[220],"selection":[221],"will":[225]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}